LifeStance Health Group, Inc. Operating Lease Cost
LifeStance Health Group, Inc. (LFST) reported Operating Lease Cost of $14.90 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-08-06
- LifeStance Health Group, Inc. operating lease, cost for the quarter ending 2026-06-30 was $14.90M, a 5.03% increase year-over-year.
- LifeStance Health Group, Inc. operating lease, cost for the quarter ending 2026-03-31 was $14.56M, a 4.00% increase year-over-year.
- LifeStance Health Group, Inc. operating lease, cost for the quarter ending 2025-12-31 was $14.41M, a 4.12% increase year-over-year.
- LifeStance Health Group, Inc. operating lease, cost for the quarter ending 2025-09-30 was $14.33M, a 3.71% increase year-over-year.
- LifeStance Health Group, Inc. operating lease, cost for fiscal 2025 was $56.92M, a 3.36% increase from fiscal 2024.
- LifeStance Health Group, Inc. operating lease, cost for fiscal 2024 was $55.07M, a 2.84% decline from fiscal 2023.
- LifeStance Health Group, Inc. operating lease, cost for fiscal 2023 was $56.68M, a 4.54% increase from fiscal 2022.
- LifeStance Health Group, Inc. operating lease, cost for fiscal 2022 was $54.22M.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $14.90M 10-Q · filed 2026-08-06 | $29.46M 10-Q · filed 2026-08-06 | $43.87M derived: sum of 3 quarters · filed 2026-08-06 | $58.20M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $14.56M 10-Q · filed 2026-05-07 | $28.97M derived: sum of 2 quarters · filed 2026-05-07 | $43.30M derived: sum of 3 quarters · filed 2026-05-07 | $57.48M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $14.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $28.74M derived: sum of 2 quarters · filed 2026-02-25 | $42.92M derived: sum of 3 quarters · filed 2026-08-06 | $56.92M 10-K · filed 2026-02-25 |
| 2025-09-30 | $14.33M 10-Q · filed 2025-11-06 | $28.51M derived: sum of 2 quarters · filed 2026-08-06 | $42.51M 10-Q · filed 2025-11-06 | $56.35M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $14.18M 10-Q · filed 2026-08-06 | $28.18M 10-Q · filed 2026-08-06 | $42.02M derived: sum of 3 quarters · filed 2026-08-06 | $55.84M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $14.00M 10-Q · filed 2026-05-07 | $27.84M derived: sum of 2 quarters · filed 2026-05-07 | $41.66M derived: sum of 3 quarters · filed 2026-05-07 | $55.39M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $13.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $27.66M derived: sum of 2 quarters · filed 2026-02-25 | $41.39M derived: sum of 3 quarters · filed 2026-02-25 | $55.07M 10-K · filed 2026-02-25 |
| 2024-09-30 | $13.82M 10-Q · filed 2025-11-06 | $27.55M derived: sum of 2 quarters · filed 2025-11-06 | $41.23M 10-Q · filed 2025-11-06 | $55.07M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $13.73M 10-Q · filed 2025-08-07 | $27.41M 10-Q · filed 2025-08-07 | $41.25M derived: sum of 3 quarters · filed 2026-02-25 | $55.52M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $13.68M 10-Q · filed 2025-05-07 | $27.52M derived: sum of 2 quarters · filed 2026-02-25 | $41.79M derived: sum of 3 quarters · filed 2026-02-25 | $56.05M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $13.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $28.11M derived: sum of 2 quarters · filed 2026-02-25 | $42.37M derived: sum of 3 quarters · filed 2026-02-25 | $56.68M 10-K · filed 2026-02-25 |
| 2023-09-30 | $14.27M 10-Q · filed 2024-11-07 | $28.53M derived: sum of 2 quarters · filed 2024-11-07 | $42.84M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $14.26M 10-Q · filed 2024-08-08 | $28.57M 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | $14.31M 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | $54.22M 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |